The new solution leverages real-time data and AI-driven insights to enhance early sepsis detection, optimize clinical workflows, and improve patient outcomes. ...
The acquisition strengthens MoveUP’s AI capabilities, optimizing musculoskeletal diagnostics, predictive analytics, and personalized rehabilitation strategies for enhanced patient outcomes. ...
GentleBeam™ aims to enhance Image-Guided SRT for nonmelanoma skin cancer, reinforcing SkinCure Oncology’s commitment to patient-centered, nonsurgical care. ...
Zimmer Biomet Secures FDA Clearance for Persona® Revision SoluTion™ Femur, Expanding Options for Metal-Sensitive Knee Implant Patients...
Largest head-to-head TAVR study highlights Evolut’s lower bioprosthetic valve dysfunction and improved durability in patients with small aortic annulus, reinforcing clinical decision-making in transcatheter valve therapy....
Court ruling dismisses claims against Co-Diagnostics, reinforcing the company’s commitment to transparency and innovation in molecular diagnostics....
Strategic agreement integrates Optellum’s AI-powered lung nodule analysis with Volpara’s early cancer detection tools, enabling a more comprehensive approach to patient risk evaluation....
Single-use sleeve offers enhanced protection against contamination while improving efficiency for healthcare professionals....
The acquisition adds the ultrasound-based TIVUS™ system to Boston Scientific’s interventional portfolio, enhancing treatment options for hypertension and expanding its presence in renal denervation therapy. ...
The acquisition strengthens NAMSA’s leadership in medical device biological safety testing, adding expertise, lab capacity, and scientific resources to support global manufacturers....